[ad_1] Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker…
Read More »Johnson & Johnson
[ad_1] Wall Street just pulled off its biggest IPO in four months, giving bankers hope that the market for newly-listed…
Read More »
[ad_1] Catalent stock surged nearly 25% in premarket trading Monday following a report that life sciences company Danaher has expressed…
Read More »
[ad_1] Dexcom’s latest continuous glucose monitoring (CGM) system, to launch in February, will be 60% smaller and warm up 75%…
Read More »
[ad_1] As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer…
Read More »
[ad_1] CNBC’s Jim Cramer on Tuesday gave investors a list of stocks that he believes will perform well next year.…
Read More »
[ad_1] Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded…
Read More »
[ad_1] Stock futures traded lower Monday as investors remained keyed on interest rate policy from the Federal Reserve and as…
Read More »
[ad_1] Sometimes, a single worry grows so large that it obscures all the good things happening at the same time.…
Read More »
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s…
Read More »